Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancer

Pancreatic cancer (PanCa) is projected to become the second major cause of cancer-related mortality by 2030. The current diagnostic and treatment strategies offer only marginal benefits in overall survival. This highlights the need to discover new biomarkers and targets for the treatment of PanCa. D...

Full description

Bibliographic Details

Published in:	Translational Oncology
Main Authors:	Mudassier Ahmad, Sahir Sultan Alvi, Anupam Dhasmana, Jasmine Benavidez, Murali M Yallapu, Dae Joon Kim, Subhash C Chauhan, Bilal Bin Hafeez
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Subjects:	Pancreatic cancer (PanCa) Mitochondrial ribosomal proteins (MRPs) Mitochondrial ribosomal protein L3 (MRPL3) Biomarker NADH-Ubiquinone Oxidoreductase Core Subunit 1 (NDUFS1)
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523325001639